ID: ALA3218935

Max Phase: Preclinical

Molecular Formula: C20H11BrCl3N3O2

Molecular Weight: 511.59

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1nc2ccc(Br)cn2cc1Cc1cccc(Oc2nc(Cl)c(Cl)cc2Cl)c1

Standard InChI:  InChI=1S/C20H11BrCl3N3O2/c21-13-4-5-17-25-19(28)12(9-27(17)10-13)6-11-2-1-3-14(7-11)29-20-16(23)8-15(22)18(24)26-20/h1-5,7-10H,6H2

Standard InChI Key:  KGEQRAWIRMPHOH-UHFFFAOYSA-N

Associated Targets(Human)

Dihydrofolate reductase 3072 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-N-SH 1499 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 511.59Molecular Weight (Monoisotopic): 508.9100AlogP: 6.20#Rotatable Bonds: 4
Polar Surface Area: 56.49Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 5.79CX LogD: 5.79
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.31Np Likeness Score: -1.23

References

1. Rapolu S, Alla M, Ganji RJ, Saddanapu V, Kishor C, Bommena VR, Addlagatta A.  (2013)  Synthesis, cytotoxicity and hDHFR inhibition studies of 2H-pyrido[1,2-a]pyrimidin-2-ones,  (5): [10.1039/C3MD00013C]

Source